Abstract. circadian rhythms are daily oscillations in various biological processes, generated by the feedback loops of eight core circadian genes: Clock, Bmal1 and Casein Kinase I ε (CKIε). recent studies have suggested that circadian genes participate in the growth and development of various cancers. this study examined the relations of circadian gene expression to clinicopathological factors and outcomes in patients with colorectal cancer. We studied surgical specimens of cancer tissue and adjacent normal mucosa obtained from 202 patients with untreated colorectal cancer. the relative expression levels of the circadian genes in the specimens were measured by quantitative real-time, reverse-transcription polymerase chain reaction. expression of the Clock gene and the CKIε gene in cancer tissue were significantly higher compared to that in adjacent normal mucosa. expression of the Per1 and Per3 genes in cancer tissue was significantly lower compared to that in adjacent normal mucosa. Analysis of the relations between clinicopathological features and expression of the eight circadian genes in cancer tissue showed that high expression of the Bmal1 gene and low expression of the Per1 gene correlated with liver metastasis. on analysis of the relations between outcomes and gene expression, high expression of the Per2 gene was associated with significantly better outcomes than low expression of the Per2 gene. overexpression of the Bmal1 gene and reduced expression of the Per1 gene may thus be useful predictors of liver metastasis. Moreover, reduced expression of the Per2 gene may be a predictor of outcomes in patients with colorectal cancer.
Introduction
circadian rhythms are daily oscillations in various biologic processes. In mammals, the master circadian pacemaker is located in the suprachiasmatic nuclei (scn) (1) . the master circadian clock coordinates peripheral circadian clocks within virtually every cell in the body (2) . this coordination is accomplished directly through autonomic nervous system innervation and indirectly through daily rhythmic synthesis and release of an array of hypothalamic, pituitary, and dispersed endocrine hormones (3) (4) (5) (6) . the molecular mechanism of circadian oscillation in the scn and peripheral cells is based on the feedback loops of eight core circadian genes (3, 7, 8) . these eight genes are Period1 (Per1), Period2 (Per2), Period3 (Per3), Cryptochrome1 (Cry1), Cryptochrome2 (Cry2), Clock, Bmal1, and Casein Kinase I ε (CKIε) . the feedback loops of the eight core circadian genes are as follows. the Clock gene remains steady throughout the 24-h day. High levels of Bmal1 promote the formation of Bmal1/clock heterodimers. these heterodimers bind to e-box sequences in the promoters of the Cry and Per genes to activate transcription. Bmal1/clock heterodimers can also inhibit Bmal1 transcription. After transcription and translation, the per proteins accumulate in the cytoplasm and are phosphorylated by cKIε. the phosphorylated forms of per are unstable and are degraded by ubiquitylation. cry accumulates in the cytoplasm, promoting the formation of stable per/cry/cK1ε complexes, which enter the nucleus. once in the nucleus, cry disrupts the Bmal1/clock-associated transcriptional complex, resulting in the inhibition of cry and per transcription and the derepression of Bmal1 transcription (Fig. 1 ). In the peripheral tissues, the molecular clock coordinates the transcription of the circadian genes. the circadian genes are largely tissue specific and link key tissue functions to the circadian environ-ment, making these key functions available at specific times during each day, when they are most needed (9) (10) (11) .
Disruption of circadian organization has significant effects on human health, causing sleep disorders, gastrointestinal and cardiovascular illnesses, and depression. It is also associated with an increased incidence of several epithelial cancers (12-15). In mouse models, transplanted tumors grow twice as fast in scn-lesioned mice than in sham-lesioned animals (16) . these studies have suggested a close connection between circadian organization and the development of various cancers. relations between circadian genes and cancer have been demonstrated in recent years. the host circadian clock has been reported to play an important role in the endogenous control of tumor progression (16) . As for circadian genes, Bmal1 was shown to be a positive regulator of tumor growth and metastasis in cancer (17) . Moreover, overexpression of per1 in prostate cancer cells causes significant growth inhibition and apoptosis (18) . In addition, per2 plays a key role in tumor suppression, controlled by genes such as c-myc and cyclin D1 through the activity of Bmal1/clock heterodimers (19) , and Per2 gene overexpression induces cancer cell apoptosis (20) . per2 overexpression has also been found to inhibit the growth of pancreatic cancer cells and to act synergistically with cisplatin (21) . However, studies assessing the relations of circadian gene expression to clinicopathological features and outcomes in colorectal cancer have not been reported. We therefore examined whether the expressions of circadian genes were related to clinicopathological characteristics and outcomes in patients with colorectal cancer.
Materials and methods
Patients and samples. We studied surgical specimens of cancer tissue and adjacent normal mucosa obtained from 202 patients with untreated colorectal cancer. the patients underwent surgery at yokohama city Medical center, gastroenterological center, and at Kanagawa cancer center from january 2002 through january 2005. the duration of observation was longer than 5 years. Informed consent was obtained from each patient, and the ethics committees of yokohama city Medical center and Kanagawa cancer center approved the protocol before initiation of the study.
All tissue samples were embedded in o.c.t. compound (sakura Finetechnical co., ltd., tokyo, japan) and immediately stored at -80˚C until use. No patient had any other malignancies. the histopathological features of specimens stained with hematoxylin and eosin were examined, and sections that consisted of >80% cancer cells were used to prepare total rnA.
Quantitative real-time, reverse-transcription polymerase chain reaction (PCR). total rnA isolated from colorectal cancer and adjacent normal mucosa was prepared with the use of trIzol (gibco, life tech, gaithersburg, Md, usA). complementary dnA (cdnA) was synthesized from 2 µg of total rnA with an iscript cdnA synthesis Kit (Bio-rad laboratories, Hercules, cA, usA). After synthesis, the cdnA was diluted 1:4 with water and stored at -20˚C until use. Quantitative real-time pcr was performed with an iQ syBrgreen supermix (Bio-rad laboratories). pcr reactions were carried out in a total volume of 15 µl containing cdnA derived from 75 ng of mrnA, 0.27 µM of each primer, 7.5 µl of iQ syBr-green supermix containing dAtp, dctp, dgtp, and dttp at concentrations of 400 µM each, and 50 units/ml of iTag DNA polymerase. The PCR consisted of 10 min at 94˚C, followed by 50 cycles of denaturation of the cdnA for 30 sec at 94˚C, annealing for 30 sec at an appropriate temperature (Table I) , and a primer extension for 1 min at 72˚C followed by 10 min at 72˚C. The PCR primer sequences of Per1, Per2, Per3, Cry1, Cry2, Clock, Bmal1, CK1ε, and β-actin, used as an internal control, are shown in table I.
Statistical analysis. gene expression levels of colorectal cancer were compared with those of adjacent normal mucosa by the Wilcoxon test. relations between gene expression and potential explanatory variables, including age, gender, tumor size, histological type, depth of invasion, lymph node metastasis, location, lymphatic invasion, venous invasion, and liver metastasis, were evaluated with the χ 2 test. the postoperative survival rate was analyzed by the Kaplan-Meier method, and differences in survival rates were assessed with the log-rank test. A cox proportional hazard regression model was used for multivariate analyses. All statistical analyses were performed using IBM spss statistics 18.0 (spss, Inc., chicago, Il, usA). two-sided p-values were calculated, and a difference was considered significant if the P-value was <0.05.
Results

Comparison of circadian gene mRNA expression between colorectal cancer tissue and adjacent normal mucosa. Clock
and CK1ε gene expression levels were higher in cancer than in adjacent normal mucosa (P<0.0001, P<0.0001; Fig. 2F and H). Per1 and Per3 gene expression levels were higher in adjacent Figure 1 . the feedback loops of eight core circadian genes. the molecular mechanism of circadian oscillation in the scn and peripheral cells is based on the feedback loops of eight core circadian genes. the Clock gene remains steady throughout the 24-h day. High levels of Bmal1 promote the formation of Bmal1/clock heterodimers. these heterodimers bind to e-box sequences in the promoters of the Cry and Per genes to activate transcription. Bmal1/ clock heterodimers can also inhibit Bmal1 transcription. After transcription and translation, the per proteins accumulate in the cytoplasm and are phosphorylated by cKIε. the phosphorylated forms of per are unstable and are degraded by ubiquitylation. cry accumulates in the cytoplasm, promoting the formation of stable per/cry/cK1ε complexes, which enter the nucleus. once in the nucleus, cry disrupts the Bmal1/clock-associated transcriptional complex, resulting in the inhibition of cry and per transcription and the derepression of Bmal1 transcription.
normal mucosa than in cancer (p=0.043, p=0.010; Fig. 2A and c). Per2, Cry1, Cry2, and Bmal1 gene expression levels were similar in cancer and adjacent normal mucosa ( Fig.  2B-g ).
Relations of circadian gene expression levels to clinicopathological features. expression levels of the circadian genes were categorized as low or high according to their median values. the relations between the expression levels of these genes and clinicopathological features were then examined. expression levels of the circadian genes were unrelated to age, gender, tumor size, lymph node metastasis, lymphatic invasion, and venous invasion. High expression of the Bmal1 gene and low expression of the Per1 gene correlated with liver metastasis (table II) .
Relations of Bmal1 and Per1 gene expression levels to liver metastasis. the highest rate of liver metastasis was associated with high expression of the Bmal1 gene and low expression of the Per1 gene (Fig. 3) . Clock and CK1ε gene expression levels were higher in cancer than in adjacent normal mucosa (P<0.001). Per1 and Per3 gene expression levels were higher in adjacent normal mucosa than in cancer. Per2, Cry1, Cry2, and Bmal1 gene expression levels were similar in cancer and adjacent normal mucosa. 
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Variables/categories low (n=101) High (n=101) p-value low (n=101) High (n=101) p-value low (n=101) High (n=101) p-value low (n=101) High (n=101) p-value Univariate analysis of clinicopathological factors and the expression levels of the circadian genes for outcomes. univariate analysis revealed that tumor size, serosal invasion, lymph node metastasis, lymphatic invasion, liver metastasis, and the expression of the Per2 gene positively influenced outcomes (table III) .
Multivariate analysis of clinicopathological factors and the expression levels of the circadian genes for outcomes. on multivariate analysis using cox proportional hazard regression analysis, the expression of Per2 gene expression was an independent variable affected outcomes of patients with colorectal cancer (p=0.006) (table IV). survival time was determined using the Kaplan-Meier method and compared using the log-rank test. Wel, well differentiated adenocarcinoma; mod, moderately differentiated adenocarcinoma; por, poorly differentiated adenocarcinoma.
survival rate (%) -------------------------------------------
Relations between expressions of the circadian genes and outcomes. High expression of the Per2 gene was associated with significantly better outcomes than low expression of the Per2 gene (p=0.0048) (Fig. 4) .
Discussion
In this study, we examined the expression levels of circadian genes in colorectal cancer and in adjacent normal mucosa. We also studied the relations of the expression levels of these genes to outcomes and clinicopathological features. our results suggest that overexpression of the Bmal1 gene and reduced expression of the Per1 gene are useful predictors of liver metastasis, whereas reduced expression of the Per2 gene is linked to poor outcomes in patients with colorectal cancer. several previous studies have compared expression levels of circadian regulators between cancer tissue and adjacent normal mucosa. one study found that 95% of breast cancer tissue samples displayed loss or deregulated levels of per1 and per3 proteins as compared with adjacent normal tissue (22) . Moreover, the expressions of per1 and per2 in both sporadic and familial primary tumors are significantly lower than those in normal breast tissues (23) . In human endometrial carcinoma, loss of per1 protein is commonly observed in tumor cells, but not in the adjacent normal cells (24) . A metaanalysis of microarray expression studies showed that Per1 is down-regulated in human prostate cancer as compared with normal prostate tissue (18) . CK1ε gene expression was found to be overexpressed in six kinds of cancer tissues as compared with adjacent normal tissues (25) . In our study, Per1 and Per3 gene expression levels were lower in cancer than in adjacent normal mucosa. In contrast, CK1ε and Clock gene expression levels were higher in cancer than in adjacent normal mucosa. these results seem to be reasonable for the following reasons. overexpression of CKIε induces the phosphorylation and degradation of the period. reduced period expression in turn decreases the formation of per/cry/cK1ε complexes. Because per/cry/cK1ε complexes inhibit the activity of Bmal1/clock heterodimers, reduced levels of the former promote the activity of the latter. overexpression of clock also increases Bmal1/clock heterodimers, which induce cyclin D1 expression (19) . cyclin d1 promotes the proliferation of cancer cells (26) .
We then examined the relations of the expression levels of circadian genes to clinicopathological features. High expression of the Bmal1 gene and low expression of the Per1 gene correlated with liver metastasis. We next examined the relations of Bmal1 and per1 gene expression levels to liver metastasis. several previous studies have examined Bmal1 and per1. Bmal1 was suggested to be a positive regulator of tumor growth and metastasis, acting by expressing vascular endothelial growth factor in cancer (27) . Bmal1 epigenetic inactivation contributes to the development of hematologic malignancies by disrupting the cellular circadian clock (28) . per1 inactivation is thought to play an important role in carcinogenesis (29) . Moreover, overexpression of per1 in cancer cells leads to significant growth inhibition and apoptosis (24) . In our study, high expression of the Bmal1 gene and low expression of the Per1 gene correlated with liver metastasis. overexpression of the Bmal1 gene and reduced expression of the Per1 gene might thus promote liver metastasis through the following mechanism. reduced per1 expression decreases the formation of per/cry/cKIε complexes. reduced levels of these complexes promote the activity of Bmal1/clock heterodimers. overexpression of Bmal1 also increases the activity of Bmal1/ clock heterodimers, which induce cyclin d1 expression (19) . High levels of cyclin d1 expression increase cancer cell proliferation (26) , thereby, promoting liver metastasis.
Finally, we examined the relations between the expressions of circadian genes and outcomes. In the expressions of circadian genes, only the expression of the Per2 gene positively influenced outcomes of patients with colorectal cancer in the univariate analysis. Moreover, the expression of the Per2 gene was an independent variable affecting outcomes on multivariate analysis using cox proportional hazard regression analysis. previous studies examining the relation between per2 and cancer have reported that mice without functional per2 are prone to develop cancer and display altered expression of genes involved in cell cycle regulation, tumor suppression, and apoptosis regulation, such as cyclin D1, cyclin A, p53, c-Myc, Mdm2, and Bcl-2. In particular, c-Myc is controlled by Per2 through the activity of Bmal1/clock heterodimers (19) . overexpression of the Per2 gene induces cancer cell apoptosis (20) , and inhibits the neoplastic growth of cancer cells (30) . Moreover, Per2 gene mutations have been identified in human colorectal and breast cancers (31) , and overexpression of per2 inhibits tumor proliferation in culture as well as in animals (32, 33) . In our study, high expression of the Per2 gene was associated with significantly better outcomes than low expression of the Per2 gene. reduced expression of the Per2 gene might thus shorten survival in patients with colorectal cancer. the following mechanism is thought to be involved. reduced expression of the Per2 gene decreases the activity of Bmal1/clock heterodimers, leading to the induction of c-Myc. High levels of c-Myc promote cancer cell proliferation, and reduced expression of per2 decreases p53 and increases Bcl-2. reduced p53 expression and increased Bcl-2 expression repress apoptosis and promote cancer cell survival. Increased cancer cell proliferation and survival lead to poor outcomes.
In conclusion, our results suggest that overexpression of the Bmal1 gene and reduced expression of the Per1 gene are useful predictors of liver metastasis. Moreover, reduced expression of the Per2 gene may be a predictor of outcomes in patients with colorectal cancer.
